MedPath

Feasibility Study of Unified Protocol for Anxiety and Depressive Disorders

Phase 1
Conditions
Anxiety Disorders, Depressive Disorders
Registration Number
JPRN-UMIN000008322
Lead Sponsor
ational Center of Neurology and Psychiatry, National Center for Cognitive Behavior Therapy and Research
Brief Summary

The severity of anxiety symptoms decreased significantly after the intervention and remained low for 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
17
Inclusion Criteria

Not provided

Exclusion Criteria

1. No alcohol or substance use disorder in 6 months prior to the screening. 2. No history or concurrent manic or psychotic episode. 3. No other primary DSM-IV Axis I Disorders in six months prior to the screening. 4. No comorbid of antisocial personality disorder. 5. No serious suicidal ideation at screening. 6. Evidence of unable to participate half or more of the intervention phase. 7. No past treatment of CBT. 8. No structured psychotherapy (except supportive therapy) during the intervention. 9. No major cognitive deficits at screening. 10. No life-threatening, severe or unstable physical disorders at screening. 11. Other relevant reason decided by the investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath